| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $62K | -46.9% | -54.9% |
| SG&A Expense | $833K | -1.9% | -4.1% |
| Operating Income | -$895K | +7.3% | +11.1% |
| Net Income | -$873K | +8.8% | +10.1% |
| EPS (Basic) | -$1.81 | -302.2% | -138.2% |
| EPS (Diluted) | -$1.81 | -302.2% | -138.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.8M | +505.1% | +46.5% |
| Current Assets | $6.1M | +346.1% | +58.7% |
| Total Assets | $6.1M | +337.8% | +58.0% |
| Total Liabilities | $1.8M | -16.8% | +97.8% |
| Stockholders' Equity | $4.2M | +612.0% | +45.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Investing Cash Flow | -$200K | — | — |
| Financing Cash Flow | $6.3M | — | — |